Interleukin 34, from pathogenesis to clinical applications.
about
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential.Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report.
P2860
Interleukin 34, from pathogenesis to clinical applications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Interleukin 34, from pathogenesis to clinical applications.
@en
type
label
Interleukin 34, from pathogenesis to clinical applications.
@en
prefLabel
Interleukin 34, from pathogenesis to clinical applications.
@en
P2093
P1433
P1476
Interleukin 34, from pathogenesis to clinical applications
@en
P2093
Haruka Wada
Hiraku Endo
Ken-Ichiro Seino
Yoshino Tanaka
P304
P356
10.1016/J.CYTO.2017.08.020
P577
2017-09-05T00:00:00Z